DMU-212

Modify Date: 2024-01-09 17:58:57

DMU-212 structure	Common Name	DMU-212
	CAS Number	134029-62-2	Molecular Weight	300.349
	Density	1.1±0.1 g/cm3	Boiling Point	444.0±40.0 °C at 760 mmHg
	Molecular Formula	C₁₈H₂₀O₄	Melting Point	N/A
	MSDS	USA	Flash Point	144.1±34.2 °C

Use of DMU-212

DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has oral bioavailability[1][2].

Name	1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene
Synonym	More Synonyms

Description	DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has oral bioavailability[1][2].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Signaling Pathways >> MAPK/ERK Pathway >> ERK Signaling Pathways >> Stem Cell/Wnt >> ERK
In Vitro	DMU-212 (0.3125-40 μM) inhibits growth of A375, MeWo, Bro and M5 cells human melanoma cells[1]. DMU-212 (30-50 μM; 24 hours) induces upregulation of cell cycle inhibitors, apoptosis and ERK activation in A375 cells[1]. DMU-212 induces upregulation of cell cycle inhibitors, apoptosis and ERK activation in A375 cells[1]. DMU-212 induces G2/M arrest and apoptosis in cancer cells[1]. DMU-212 induces mitotic arrest, apoptosis and activation of ERK1/2 protein[1]. Cell Proliferation Assay[1] Cell Line: A375 cells, MeWo cells, M5 cells, Bro cells Concentration: 0.3125 μM, 0,625 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM, 20 μM, 40 μM Incubation Time: 96 hours Result: Inhibited the cellular proliferation of human melanoma cells at submicromolar or micromolar concentrations (IC50=0.5 μM for A375 and Bro and IC50= 1.25 μM for MeWo and M5 cells). Cell Cycle Analysis[1] Cell Line: A375 cells Concentration: 20 μM, 30 μM, 50 μM Incubation Time: 24 hours Result: Caused a marked increase in the levels of p21, p53 and cyclin B1 proteins with a concomitant decrease in the levels of cyclin A2. Western Blot Analysis[1] Cell Line: A375 cells Concentration: 20 μM, 30 μM, 50 μM Incubation Time: 24 hours Result: Significant upregulation of Bax, caspase 3 and caspase 9 protein levels, while the levels of the anti-apoptotic protein Bcl-2 were decreased.
In Vivo	DMU-212 (50 mg/kg; i.g.; three times a week; for 14 days) inhibits tumor growth in xenograft model of human ovarian cancer[2]. Animal Model: 6-weeks-old SCID female mice (20-24 g), with ovarian cancer xenografts[2] Dosage: 50 mg/kg Administration: Oral gavage, three times a week, for 14 days Result: Lower tumor burden.
References	[1]. Vasilis Pericles Androutsopoulos, et al. Activation of ERK1/2 is required for the antimitotic activity of the resveratrol analogue 3,4,5,4'-tetramethoxystilbene (DMU-212) in human melanoma cells. Exp Dermatol. 2015 Aug;24(8):632-4. [2]. Hanna Piotrowska, et al. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer. Biomed Pharmacother. 2014 May;68(4):397-400.

Density	1.1±0.1 g/cm3
Boiling Point	444.0±40.0 °C at 760 mmHg
Molecular Formula	C₁₈H₂₀O₄
Molecular Weight	300.349
Flash Point	144.1±34.2 °C
Exact Mass	300.136169
PSA	36.92000
LogP	4.37
Vapour Pressure	0.0±1.0 mmHg at 25°C
Index of Refraction	1.588

RIDADR	NONH for all modes of transport

Precursor 9
CAS#:1530-38-7 (4-Methoxybenzy... CAS#:86-81-7 3,4,5-Trimethox... CAS#:2746-25-0 1-bromomethyl-4... CAS#:3840-31-1 (3,4,5-Trimetho...
CAS#:3462-97-3 (4-Methoxybenzy... CAS#:123-11-5 4-Methoxybenzal... CAS#:134029-74-6 [(3,4,5-trimeth... CAS#:637-69-4 4-Methoxystyrene
CAS#:2675-79-8 5-Bromo-1,2,3-t...
DownStream 0